1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic and clinical features
Characteristic MS (n = 107) PC (n = 36) P Sex (No.) (%) .78 Female 74 (69%) 24 (67%) Male 33 (31%) 12 (33%) Age (yr) .36 Median (IQR) 32 (17–43) 39 (15–54) Range 9–60 8–74 Age group (No.) (%) .42 Pediatric 31 (29%) 13 (36%) Adult 76 (71%) 23 (64%) Clinical course (No.) (%) – RRMS 107 (100%) 0 Possible PC 0 10 (28%) Definite PC 0 26 (72%) Disease duration (yr) Median (IQR) 4 (1–8) – Range 0–33 – EDSS score – Median (IQR) 1.5 (1.0–2.0) – Range 0.0–6.0 –
Note:—RRMS indicates relapsing-remitting MS.